United States Electroporation Instruments and Consumables Market to Reach US$ 117.72 Million by 2031 | North America leads with 40% share | Top Companies - Thermo Fisher Scientific Inc., Bio-Rad Laboratories, BEX Co. Ltd

Leander, Texas and Tokyo, Japan - Jan.28.2026
As per DataM intelligence research report "The Global Electroporation Instruments and Consumables Market size reached USD 233.4 million in 2022 and is projected to witness lucrative growth by reaching up to USD 392.4 million by 2031. The market is exhibiting at a CAGR of 6.8% during the forecast period (2024-2031)."

Growth is supported by rising use in gene therapy, oncology, and cell-based research. Research institutes and biotech companies dominate end-users. Advances in precision medicine and life sciences research drive adoption.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/electroporation-instruments-and-consumables-market?prasad
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Electroporation Instruments and Consumables Market: Competitive Intelligence
Thermo Fisher Scientific Inc., Bio-Rad Laboratories, BEX Co. Ltd, Celetrix LLC, Merck KGaA, Eppendorf AG, Harvard Bioscience Inc. (BTX)

In the Electroporation Instruments and Consumables Market, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, BEX Co. Ltd, Celetrix LLC, Merck KGaA, Eppendorf AG, and Harvard Bioscience Inc. (BTX) are key players providing advanced electroporation devices and consumables for molecular biology, cell therapy, and biotechnology research. These companies develop electroporators, cuvettes, and specialized accessories that enable efficient delivery of DNA, RNA, proteins, and drugs into cells, enhancing transfection efficiency, cell viability, and experimental reproducibility. Their focus on precision, reliability, and application-specific solutions reinforces the Electroporation Instruments and Consumables Market as a critical segment in life sciences research and therapeutics.

The market is strengthened by complementary capabilities across instrument innovation, consumable development, and application support. Thermo Fisher Scientific Inc. and Bio-Rad Laboratories lead with high-performance electroporation instruments and comprehensive consumable kits for academic and industrial research. BEX Co. Ltd. and Celetrix LLC focus on specialized electroporation solutions for clinical and therapeutic applications, including cell and gene therapy. Eppendorf AG and Merck KGaA contribute advanced laboratory instruments, reagents, and consumables that enhance experimental reproducibility. Harvard Bioscience Inc. (BTX) specializes in electroporation systems and accessories optimized for a wide range of cell types and laboratory workflows.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/electroporation-instruments-and-consumables-market?prasad
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Fund Raisings

✅ January 2026 - MaxCyte (United States)
MaxCyte raised growth capital to expand its electroporation instrument platforms and consumable products for cell and gene therapy applications. The funding supports increased production capacity and global market expansion.

✅ December 2025 - BTX Harvard Apparatus (United States)
BTX secured additional funding to advance its electroporation instrument line and single-use consumables for research and clinical use. The investment aims to accelerate R&D and improve instrument accessibility to laboratories.

✅ November 2025 - Nepagene Co., Ltd. (Japan)
Nepagene raised strategic investment to expand its electroporation consumables and nucleic acid delivery systems for academic and industrial research. The funding supports product development and distribution within Japan and Asia-Pacific markets.

Product Launches & Partnerships

✅ January 2026 - Lonza (United States)
Lonza launched next-generation electroporation instruments optimized for high-efficiency gene editing and cell therapy applications. The platform integrates user-friendly software and standardized consumables for reproducible results.

✅ December 2025 - BTX Harvard Apparatus (United States)
BTX introduced a new electroporation consumables line compatible with its research instruments to enhance reproducibility and cell viability. The launch improves workflow efficiency for laboratories performing gene transfer and transfection studies.

✅ October 2025 - Nepagene Co., Ltd. (Japan)
Nepagene unveiled advanced electroporation devices for preclinical research and industrial biotechnology applications. The products focus on high-throughput and precise nucleic acid delivery in mammalian cells.

Mergers & Acquisitions

✅ January 2026 - MaxCyte (United States)
MaxCyte acquired a small electroporation consumables supplier to enhance its supply chain and product integration. The acquisition strengthens MaxCyte's global footprint in cell and gene therapy markets.

✅ November 2025 - Nepagene Co., Ltd. (Japan)
Nepagene acquired a Japanese microfluidics firm to integrate precision delivery technologies into its electroporation instruments. The deal expands research capabilities and product offerings in life sciences.

✅ October 2025 - BTX Harvard Apparatus (United States)
BTX acquired a specialized biotech consumables company to expand its electroporation accessories and single-use product lines. The acquisition enhances laboratory workflow efficiency and product availability.

Segment Covered in the Electroporation Instruments and Consumables Market:
By Product
The market is segmented into Instruments 60% and Consumables 40%, with instruments dominating due to high demand for advanced electroporation systems in research laboratories and therapeutic applications. Consumables are growing steadily with recurring usage in experiments and clinical procedures.

By Application
Applications include Protein Production 35%, Bio-Medical Research 40%, and Therapeutic Delivery 25%, with bio-medical research leading due to the increasing adoption of electroporation in gene editing, cell transfection, and molecular biology studies. Protein production and therapeutic delivery are gaining momentum with the rise of biopharmaceuticals and personalized medicine.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=electroporation-instruments-and-consumables-market
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Regional Analysis
North America - 40% Share
North America leads with 40% share driven by strong R&D infrastructure, high adoption of advanced electroporation instruments in universities, biotech companies, and hospitals in the U.S. and Canada.

Europe - 25% Share
Europe holds 25% share supported by research activities, gene therapy projects, and increasing biopharma investments in Germany, France, and the UK.

Asia Pacific - 25% Share
Asia Pacific captures 25% share fueled by expanding life sciences research, growing biotechnology industry, and government initiatives in China, India, Japan, and South Korea.

Latin America - 7% Share
Latin America accounts for 7% share driven by adoption in research laboratories and universities in Brazil, Mexico, and Argentina.

Middle East & Africa - 3% Share
Middle East & Africa holds 3% share, supported by emerging biotech research centers and healthcare infrastructure investments in GCC countries and South Africa.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.